Chen, Chu-Huang

An Updated Review of Lysophosphatidylcholine Metabolism in Human Diseases

Law, S.-H., Chan, M.-L., Marathe, G. K., Parveen, F., Chen, C.-H., & Ke, L.-Y. (2019) · International Journal of Molecular Sciences

Lipid metabolism and biosynthesisCholesterol and Lipid Metabolism

Cited by 817

Mediation of Electronegative Low-Density Lipoprotein Signaling by LOX-1: A Possible Mechanism of Endothelial Apoptosis

Lu, J., Yang, J.-H., Burns, A. R., Chen, H.-H., Tang, D., Walterscheid, J. P., Suzuki, S., Yang, C.-Y., Sawamura, T., & Chen, C.-H. (2009) · Circulation Research

Atherosclerosis and Cardiovascular DiseasesCholesterol and Lipid Metabolism

Cited by 137

Activation of acid-sensing ion channel 3 by lysophosphatidylcholine 16:0 mediates psychological stress-induced fibromyalgia-like pain

Hung, C.-H., Lee, C.-H., Tsai, M.-H., Chen, C.-H., Lin, H.-F., Hsu, C.-Y., Lai, C.-L., & Chen, C.-C. (2020) · Annals of the Rheumatic Diseases

Pain Mechanisms and TreatmentsFibromyalgia and Chronic Fatigue Syndrome Research

Cited by 65

Human electronegative LDL induces mitochondrial dysfunction and premature senescence of vascular cells in vivo

Wang, Y., Lee, A., Lu, L., Ke, L., Chen, W., Dong, J., Lu, J., Chen, Z., Chu, C., Chan, H., et al. (2018) · Aging Cell

Atherosclerosis and Cardiovascular DiseasesTelomeres, Telomerase, and Senescence

Cited by 58

Weight Change During the Postintervention Follow-up of Look AHEAD

Wing, R. R., Neiberg, R. H., Bahnson, J. L., Clark, J. M., Espeland, M. A., Hill, J. O., Johnson, K. C., Knowler, W. C., Olson, K., Steinburg, H., et al. (2022) · Diabetes Care

Diabetes, Cardiovascular Risks, and LipoproteinsDiabetes Treatment and Management

Cited by 14